EOSINOPHILIC GASTROENTERITIS

Clinical trials for EOSINOPHILIC GASTROENTERITIS explained in plain language.

Never miss a new study

Get alerted when new EOSINOPHILIC GASTROENTERITIS trials appear

Sign up with your email to follow new studies for EOSINOPHILIC GASTROENTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 3

Experimental drug targets rare, painful stomach disease

Disease control Ongoing

This study is testing an existing drug, dupilumab, to see if it can help people with eosinophilic gastritis, a chronic allergic condition where too many white blood cells cause painful stomach inflammation. The trial will enroll 22 adults and adolescents to receive the drug for u…

Matched conditions: EOSINOPHILIC GASTROENTERITIS

Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

EOSINOPHILIC GASTROENTERITIS

Get alerted when new EOSINOPHILIC GASTROENTERITIS trials appear

Experimental drug targets rare, painful stomach disease